» Articles » PMID: 37063705

Extension of the Clinicoradiologic Spectrum of Newly Described End-Truncating Variations

Abstract

Objectives: To refine the clinical spectrum of a very recently identified phenotype associated with end-truncating pathogenic variations.

Methods: Detailed clinical, neuropsychological, and MRI investigation of 6 patients from 2 unrelated families segregating end-truncating variations.

Results: All patients harbored end-truncating pathogenic variation. The specific association of a hippocampal type episodic memory dysfunction and a diffuse leukoencephalopathy was observed in all 4 patients aged older than 50 years, slightly worsening over time in 2 patients with several years of follow-up. Additional unspecific neurologic symptoms are reported, such as episodes of numbness, language troubles, or faintness in these 4 patients and the 2 younger ones.

Discussion: The association of an extensive leukoencephalopathy with an episodic memory dysfunction of the hippocampal type is strongly suggestive of a end-truncating variation in adults older than 50 years. Early cognitive complaints and imaging abnormalities might exist decades before. Additional transient manifestations can be observed, and this association should lead to screening to avoid unnecessary invasive investigations.

Citing Articles

Pathophysiology of cerebral small vessel disease: a journey through recent discoveries.

Dupre N, Drieu A, Joutel A J Clin Invest. 2024; 134(10).

PMID: 38747292 PMC: 11093606. DOI: 10.1172/JCI172841.

References
1.
Lamer S, Carlier R, Pinard J, Mompoint D, Bagard C, Burdairon E . Congenital muscular dystrophy: use of brain MR imaging findings to predict merosin deficiency. Radiology. 1998; 206(3):811-6. DOI: 10.1148/radiology.206.3.9494506. View

2.
Resende L, de Paiva A, Kok F, da Costa Leite C, Lucato L . Adult Leukodystrophies: A Step-by-Step Diagnostic Approach. Radiographics. 2019; 39(1):153-168. DOI: 10.1148/rg.2019180081. View

3.
Arreguin A, Colognato H . Brain Dysfunction in LAMA2-Related Congenital Muscular Dystrophy: Lessons From Human Case Reports and Mouse Models. Front Mol Neurosci. 2020; 13:118. PMC: 7390928. DOI: 10.3389/fnmol.2020.00118. View

4.
Geranmayeh F, Clement E, Feng L, Sewry C, Pagan J, Mein R . Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations. Neuromuscul Disord. 2010; 20(4):241-50. DOI: 10.1016/j.nmd.2010.02.001. View

5.
Pantoni L . Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010; 9(7):689-701. DOI: 10.1016/S1474-4422(10)70104-6. View